Perigon Wealth Management LLC Raises Position in Health Catalyst, Inc. (NASDAQ:HCAT)

Perigon Wealth Management LLC raised its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 34.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,697 shares of the company’s stock after purchasing an additional 10,355 shares during the period. Perigon Wealth Management LLC’s holdings in Health Catalyst were worth $377,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of HCAT. Advisor Group Holdings Inc. grew its stake in shares of Health Catalyst by 86.3% during the first quarter. Advisor Group Holdings Inc. now owns 5,324 shares of the company’s stock valued at $137,000 after buying an additional 2,467 shares during the last quarter. Fairfield Bush & CO. bought a new position in shares of Health Catalyst during the first quarter valued at approximately $25,000. Raymond James Financial Services Advisors Inc. grew its stake in shares of Health Catalyst by 118.6% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 11,157 shares of the company’s stock valued at $292,000 after buying an additional 6,053 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Health Catalyst by 4.9% during the first quarter. Bank of New York Mellon Corp now owns 750,396 shares of the company’s stock valued at $19,607,000 after buying an additional 35,022 shares during the last quarter. Finally, US Bancorp DE grew its stake in shares of Health Catalyst by 14.0% during the first quarter. US Bancorp DE now owns 9,260 shares of the company’s stock valued at $242,000 after buying an additional 1,139 shares during the last quarter. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Stock Down 2.5 %

Shares of NASDAQ HCAT opened at $5.53 on Wednesday. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $323.84 million, a PE ratio of -2.63 and a beta of 1.29. The stock’s fifty day simple moving average is $8.04 and its two-hundred day simple moving average is $8.48. Health Catalyst, Inc. has a 12-month low of $5.51 and a 12-month high of $14.37.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Thursday, February 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.06. The business had revenue of $75.08 million for the quarter, compared to analysts’ expectations of $73.67 million. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. As a group, analysts expect that Health Catalyst, Inc. will post -0.47 EPS for the current fiscal year.

Analysts Set New Price Targets

HCAT has been the topic of a number of analyst reports. Guggenheim raised Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 target price on the stock in a research note on Friday, January 26th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $16.00 target price on shares of Health Catalyst in a research note on Wednesday, April 10th. Barclays assumed coverage on Health Catalyst in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $14.00 price objective on the stock. Evercore ISI dropped their price objective on Health Catalyst from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, February 23rd. Finally, KeyCorp reissued a “sector weight” rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Health Catalyst presently has an average rating of “Moderate Buy” and a consensus target price of $12.10.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.